Cary Street Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Cary Street Partners's OGN Position: Q2 2025 in Review
Cary Street Partners sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 5,493 shares — an estimated $81.8K sold.
Cary Street Partners first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $111K in Q4 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.
- Cary Street Partners reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
- Cary Street Partners sold 5,493 Organon & Co shares in Q2 2025, an estimated $81.8K.
- Cary Street Partners first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
- Cary Street Partners's Organon & Co position peaked at $111K in Q4 2024.
- 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.
Based on Cary Street Partners's 13F filing for Q2 2025, filed 13 Aug 2025.